Hepatitis C in Hemodialysis Units: diagnosis and therapeutic approach
- PMID: 30806444
- PMCID: PMC6979573
- DOI: 10.1590/2175-8239-JBN-2018-0177
Hepatitis C in Hemodialysis Units: diagnosis and therapeutic approach
Abstract
According to data from the last census of the Brazilian Society of Nephrology (SBN), the prevalence of hepatitis C virus (HCV) in Brazilian hemodialysis units (HU) is 3.3%, about three times higher than what is reported for the Brazilian general population. Often, professionals working in HU are faced with clinical situations that require rapid HCV diagnosis in order to avoid horizontal transmission within the units. On the other hand, thanks to the development of new antiviral drugs, the cure of patients with HCV, both in the general population and in patients with chronic kidney disease and the disease eradication, appear to be very feasible objectives to be achieved in the near future . In this scenario, SBN and the Brazilian Society of Hepatology present in this review article a proposal to approach HCV within HUs.
De acordo com os dados do último censo da Sociedade Brasileira de Nefrologia (SBN), a prevalência de portadores do vírus da hepatite C (HCV) nas unidades de hemodiálise (UH) no Brasil é de 3,3%, cerca de três vezes maior do que é observado na população geral brasileira. Muitas vezes, os profissionais que trabalham nas UH deparam-se com situações clínicas que demandam rápido diagnóstico do HCV, a fim de evitar uma transmissão horizontal dentro das unidades. Por outro lado, a cura dos pacientes portadores do HCV, tanto na população geral como na portadora de doença renal crônica e a erradicação da doença, em virtude do desenvolvimento de novas drogas antivirais, parecem ser objetivos bastante factíveis, a ser alcançados em futuro próximo. Nesse cenário, a SBN e a Sociedade Brasileira de Hepatologia apresentam neste artigo de revisão uma proposta de abordagem do HCV dentro das UH.
Figures




Similar articles
-
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).J Nephrol. 2018 Oct;31(5):685-712. doi: 10.1007/s40620-018-0523-1. Epub 2018 Sep 25. J Nephrol. 2018. PMID: 30255440
-
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).Dig Liver Dis. 2018 Nov;50(11):1133-1152. doi: 10.1016/j.dld.2018.08.022. Epub 2018 Sep 12. Dig Liver Dis. 2018. PMID: 30266305
-
Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management.Kidney Int. 2018 Oct;94(4):663-673. doi: 10.1016/j.kint.2018.06.011. Kidney Int. 2018. PMID: 30243313
-
Hepatitis C virus in chronic dialysis patients.Minerva Urol Nefrol. 2005 Sep;57(3):175-97. Minerva Urol Nefrol. 2005. PMID: 15986016 Review.
-
Hepatitis C virus infection in maintenance hemodialysis patients: recommendations for diagnostics and treatment.Int J Artif Organs. 2017 Feb 10;39(12):590-595. doi: 10.5301/ijao.5000548. Epub 2017 Feb 1. Int J Artif Organs. 2017. PMID: 28165585 Review.
Cited by
-
Brazilian dialysis survey 2019.J Bras Nefrol. 2021 Apr-Jun;43(2):217-227. doi: 10.1590/2175-8239-JBN-2020-0161. J Bras Nefrol. 2021. PMID: 33513218 Free PMC article.
-
Infection with hepatitis C virus in hemodialysis patients: An overview of the diagnosis and prevention rules within a hemodialysis center (Review).Exp Ther Med. 2020 Jul;20(1):109-116. doi: 10.3892/etm.2020.8606. Epub 2020 Mar 17. Exp Ther Med. 2020. PMID: 32509002 Free PMC article. Review.
-
Brazilian Dialysis Census: analysis of data from the 2009-2018 decade.J Bras Nefrol. 2020 May 20;42(2):191-200. doi: 10.1590/2175-8239-JBN-2019-0234. J Bras Nefrol. 2020. PMID: 32459279 Free PMC article.
References
-
- Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244:359–362. - PubMed
-
- Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57:1333–1342. - PubMed
-
- Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61:S45–S57. - PubMed
-
- Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2004;65:2335–2342. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical